The Man Who Wrote the DSM Warned Us About Overdiagnosis — So Why Not Gender? - Allen Frances (#8)
Allen Frances helped shape modern psychiatry by chairing the DSM-IV Task Force and has spent years warning that psychiatric diagnosis is being applied too broadly. When Stella, Mia and Bret sit down with him, the conversation moves fluently through overdiagnosis, the autism boom and the dangers of labelling — until gender dysphoria enters the room. What follows is one of the most revealing exchanges in the podcast's run: a man whose entire career warns against diagnostic inflation drawing a very different line when it comes to gender. Essential listening.
Allen Frances is not a fringe critic of psychiatry. He chaired the task force that produced the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders — arguably the most influential document in modern mental health — and has spent the decades since warning that the profession he helped shape has gone too far. Too many diagnoses, he argues, applied to too many people for too little reason. His voice carries weight precisely because it comes from inside the institution. The early part of this conversation will feel familiar to anyone who has followed his public writing. Frances walks Stella, Mia and Bret through the logic of diagnostic caution: that labels intended to be temporary have a way of becoming permanent; that mild distress is not the same as a genuine disorder; that pharmaceutical companies have a commercial interest in expanding the boundaries of illness; and that watchful waiting, so unfashionable in clinical culture, is often the most honest and effective response. He discusses the explosion in autism diagnoses — a phenomenon he sees as partly real, partly artefact — and the way diagnosis has become entangled with identity, especially in online communities, in ways that can fix rather than free people. It is when gender dysphoria comes into view that the conversation shifts gear. Frances, who has spoken about wanting gender identity removed as a category in the DSM, holds positions on medical transition that diverge sharply from those of the hosts. The episode does not shy away from the core question: is the dramatic rise in gender dysphoria presentations a genuine clinical increase, or does social contagion play a significant role? Frances acknowledges the confusion openly — his own word — and that honest admission of uncertainty from someone of his stature is itself worth the listening time. What makes this episode unusual is that neither side retreats. The disagreement is genuine, the arguments are made directly, and the hosts press their case without the conversation collapsing into rancour. Beyond Gender has always been interested in the question of why institutions and individuals who apply rigorous scepticism to other areas of medicine seem to apply a different standard to gender. Frances provides a live case study: a man with an entire career built on diagnostic restraint who arrives, on this particular question, at markedly different conclusions from those of his interlocutors. The conversation also ranges across detransition and the legal consequences now emerging around it, puberty blockers and the absence of robust evidence for their use, and what a future edition of the DSM might look like. Nothing is resolved neatly. But that is precisely the point. Episodes that sit with genuine intellectual tension, rather than performing certainty they have not earned, are the ones that tend to matter — and this is one of them.
Watch and subscribe on YouTube
Open this episode on the Beyond Gender channel
